Yongli He

Publication Activity (10 Years)

Years Active: 2020-2020
Publications (10 Years): 1

Top Topics

Signaling Pathway

Top Venues

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Cheng Huang, Weihui Huang, Rui Wang, Yongli He
Ulinastatin Inhibits the Proliferation, Invasion and Phenotypic Switching of PDGF-BB-Induced VSMCs via Akt/eNOS/NO/cGMP Signaling Pathway. Drug design, development and therapy 14 (2020)